University of Lyon, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), Laboratory of Lyon, Antibiotic Resistance and Bacterial Virulence Unit, 31 avenue Tony Garnier, 69007 Lyon, France.
University of Copenhagen, Department of Veterinary and Animal Sciences, Stigbøjlen 4, 1870 Frederiksberg C, Denmark.
Euro Surveill. 2021 Jan;26(4). doi: 10.2807/1560-7917.ES.2021.26.4.2001359.
Antimicrobial resistance (AMR) should be tackled through a One Health approach, as stated in the World Health Organization Global Action Plan on AMR. We describe the landscape of AMR surveillance in the European Union/European Economic Area (EU/EEA) and underline a gap regarding veterinary medicine. Current AMR surveillance efforts are of limited help to veterinary practitioners and policymakers seeking to improve antimicrobial stewardship in animal health. We propose to establish the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) to report on the AMR situation, follow AMR trends and detect emerging AMR in selected bacterial pathogens of animals. This information could be useful to advise policymakers, explore efficacy of interventions, support antimicrobial stewardship initiatives, (re-)evaluate marketing authorisations of antimicrobials, generate epidemiological cut-off values, assess risk of zoonotic AMR transmission and evaluate the burden of AMR in animal health. EARS-Vet could be integrated with other AMR monitoring systems in the animal and medical sectors to ensure a One Health approach. Herein, we present a strategy to establish EARS-Vet as a network of national surveillance systems and highlight challenges of data harmonisation and bias. Strong political commitment at national and EU/EEA levels is required for the success of EARS-Vet.
抗微生物药物耐药性(AMR)应通过“同一健康”方法加以解决,这是世界卫生组织抗微生物药物耐药性全球行动计划中所阐明的。我们描述了欧盟/欧洲经济区(EU/EEA)的 AMR 监测情况,并强调了兽医领域的一个空白。当前的 AMR 监测工作对于寻求改善动物健康领域抗微生物药物管理的兽医从业者和政策制定者帮助有限。我们建议建立欧洲兽医抗微生物药物耐药性监测网络(EARS-Vet),以报告 AMR 状况、跟踪 AMR 趋势并检测选定动物病原体中的新出现的 AMR。这些信息可用于为政策制定者提供咨询、探索干预措施的效果、支持抗微生物药物管理举措、(重新)评估抗微生物药物的营销许可、制定流行病学截断值、评估动物健康中 AMR 的传播风险以及评估 AMR 的负担。EARS-Vet 可与动物和医疗部门的其他 AMR 监测系统整合,以确保采取“同一健康”方法。在此,我们提出了一项建立 EARS-Vet 作为国家监测系统网络的策略,并强调了数据协调和偏差方面的挑战。EARS-Vet 的成功需要国家和 EU/EEA 各级的强有力政治承诺。